Kühn, Dennis
Metz, Carlos
Seiler, Frederik
Wehrfritz, Holger
Roth, Sophie
Alqudrah, Mohammad
Becker, André
Bracht, Hendrik
Wagenpfeil, Stefan
Hoffmann, Mathias
Bals, Robert
Hübner, Ulrich
Geisel, Jürgen
Lepper, Philipp M.
Becker, Sören L. http://orcid.org/0000-0003-3634-8802
Funding for this research was provided by:
Projekt DEAL
Article History
Received: 3 September 2020
Accepted: 18 November 2020
First Online: 25 November 2020
Ethics approval and consent to participate
: This study received ethical clearance from the ‘Ethikkommission der Ärztekammer des Saarlandes’ in Saarbrücken, Germany (authorisation number: BU127/19). Written informed consent was obtained from all study participants and/or their legal guardians before inclusion in the study.
: Consent for publication in a scientific journal was obtained from all study participants and/or their legal guardians.
: S. L. Becker has received travel grants and speaker fees from Astellas Pharmaceuticals, Becton Dickinson, Novartis and Pfizer, and participated at Advisory Boards by Pfizer and Shionogi. All other authors have nothing to disclose.